Yatırımcı.AI

RTALB vs ECILC Comparison

Price, market cap, valuation, profitability and leverage metrics of RTALB and ECILC side by side.

RTALBECILC
StockFund

If you had invested TRY 10,000

Metric comparison

RTALB vs ECILC Comparison
MetricRTALBECILCSector median
Last price (TL)2.0064.6018.72
Daily change−0.50%−5.69%−4.53%
Market capTRY 1BTRY 44.3BTRY 4.4B
P/E20.62—18.20
P/B0.340.681.14
Dividend yield—2.04%0.90%
Return on equity1.85%−3.08%1.78%
Free float84.53%22.02%37.21%
Ratios are calculated from the latest published financial statements.

Popular comparisons

Related pages

About the RTALB vs ECILC comparison

Price, market cap, valuation multiples, profitability and leverage of RTALB (Rta Laboratuvarlari) and ECILC (Eczacıbaşı İlaç) side by side as of Sep 28, 2026, 11:40. Of the 15 metrics compared, RTALB leads in 11 and ECILC leads in 4.

Highlights: Daily change: RTALB leads (−0.50% vs −5.69%). Market cap: ECILC leads (TRY 44.3B vs TRY 1B). P/B: RTALB leads (0.34 vs 0.68). EV/EBITDA: ECILC leads (165.19 vs −218.25). EV/Sales: RTALB leads (5.49 vs 9.35). Gross margin: ECILC leads (37.83% vs 22.17%). EBITDA margin (annual): ECILC leads (11.49% vs 2.49%). Net margin (annual): RTALB leads (17.87% vs −20.86%).

Frequently asked questions

By P/E, Tie is cheaper (20.62 vs —); by P/B, RTALB trades at the lower multiple (0.34 vs 0.68).

Annual net margin is 17.87% for RTALB and −20.86% for ECILC; return on equity is 1.85% for RTALB and −3.08% for ECILC.

The leverage ratio is 11.00 for RTALB and 18.92 for ECILC; net debt/EBITDA is −8.71 for RTALB and 1.37 for ECILC. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.